SCHEMBL4925857

SCHEMBL4925857

COc1cc(CNc2c(Nc3ccc(O)c(-c4ccccn4)c3)c(=O)c2=O)ccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 2/20 0.42
GSK3A P49840 4/20 0.39
GSK3B P49841 4/20 0.39
ROCK1 Q13464 4/20 0.39
PRKG1 Q13976 3/20 0.39
ROCK2 O75116 2/20 0.39
CLK4 Q9HAZ1 1/20 0.39
PRKACA P17612 3/20 0.38
RPS6KB1 P23443 3/20 0.38
RPS6KA3 P51812 3/20 0.38
CDC42BPA Q5VT25 3/20 0.38
AURKB Q96GD4 3/20 0.38
CSNK1G3 Q9Y6M4 3/20 0.38
CHEK2 O96017 2/20 0.38
AKT1 P31749 2/20 0.38
PKN2 Q16513 2/20 0.38
HIPK4 Q8NE63 2/20 0.38
MATK P42679 1/20 0.38
NEK4 P51957 1/20 0.38
HCRTR1 O43613 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4930859 0.89 MAPKAPK2 (0.41) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4930829 0.85 MAPKAPK2 (0.44) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4928235 0.85 KDM4C (0.49) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4598269 0.82 KDM1A (0.46) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4930944 0.81 MAPKAPK2 (0.44) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4924199 0.80 KDM1A (0.47) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4928614 0.79 AURKB (0.57) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4920334 0.78 MAPKAPK2 (0.42) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL13991825 0.78 MAPKAPK2 (0.42) GSK3AGSK3BROCK1PRKG1ROCK2
SCHEMBL4919461 0.78 GPR39 (0.42) GSK3AGSK3BROCK1PRKG1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors MERCK PATENT GMBH (DE) 2008-12-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312244-A1 Squaric Acid Derivatives as Protein Kinase Inhibitors CHEK1, CHEK2, SIK1 GRM4 2480/4885GSK3A 101/4885GSK3B 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.